You need to read the last to official announcements: -
Antimicrobial Data Published in Peer-Reviewed Journal PRICE SENSITIVE 20/01/21
"Botanix’s BTX 1801 Phase 2a antimicrobial study, testing synthetic cannabidiol, is complete and
remains on track for data read out in early 1Q 2021""Finalisation of data collection is now underway to support database lock, data analysis
Update on BTX 1801 Phase 2a Clinical Study PRICE SENSITIVE 14/12/20
and generation of top-line data very early in 1Q CY2021".
You need to read the last to official announcements:...
-
- There are more pages in this discussion • 9,828 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.015(4.35%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 36.5¢ | 34.5¢ | $1.231M | 3.443M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 156338 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 444065 | 17 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |